Advertisement

---

SANGAMO BIOSCIENCES, INC.

Sangamo BioSciences Announces Presentation At The 8th Annual JMP Securities Healthcare Conference

[2013-07-02] -


Sangamo BioSciences Receives $6.4 Million Strategic Partnership Award From California Institute for Regenerative Medicine (CIRM) to Develop ZFP Therapeutic® for Beta-thalassemia

[2013-05-24] - Funding for IND Application and Clinical Trial of Novel and Potentially Curative Approach


Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic Diseases

[2013-05-20] - Production of Therapeutically Relevant Levels of Clotting Factor VIII Further Demonstrates Breadth and Leverage of this Novel Approach to Monogenic Diseases
Presentations at ASGCT Annual Meeting Highlight Broad Applicability of ZFP Technology


Sangamo BioSciences Presents Clinical Data Demonstrating HIV Reservoir Reduction in HIV-Infected Subjects Treated with ZFP Therapeutic®, SB-728-T

[2013-05-15] - Unprecedented Immune Reconstitution Drives HIV Viral Reservoir Depletion
Encouraging Preliminary Anti-Viral HIV Data during Treatment Interruption in Ongoing SB-728-T Phase 2 Trials


Sangamo BioSciences Announces Presentation at the Bank of America Merrill Lynch 2013 Health Care Conference

[2013-05-09] -


Sangamo BioSciences Reports First Quarter 2013 Financial Results

[2013-05-08] -


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers